Lanthanum Carbonate (Fosrenol ®) to Reduce Oxalate Excretion in Patients With Secondary Hyperoxaluria and Nephrolithiasis

Conditions:   Secondary Hyperoxaluria;   Nephrolithiasis Intervention:   Drug: Lanthanum Carbonate Sponsor:   Universitair Ziekenhuis Brussel Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Kidney Stones | Research